Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Melanoblasts migrate to the skin using various pathways, and understanding this process could help with skin disease research.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Loose Anagen Syndrome is more common in females and may be inherited, often confused with other hair disorders, and lacks evidence for biotin treatment effectiveness.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

A rare genetic disease causes sparse hair and early blindness due to a gene mutation.

Six genetic conditions are often linked to complete scalp hair loss in children.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

A patient lost all their hair while on rheumatoid arthritis medication.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

The 'Swiss cheese' pattern in scalp biopsies can indicate trichotillomania, not just alopecia areata.

Combining minoxidil with dutasteride and microneedling is more effective for female pattern hair loss than just dutasteride and microneedling.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

A young girl with skin and scalp conditions showed some improvement with treatment.